NCT05821231
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05821231
Title Study Evaluating the Safety and Efficacy of MEDI5752 in Combination With Stereotactic Radiotherapy in Patients With Metastatic Sarcoma (MEDISARC-SBRT)
Acronym MEDISARC-SBRT
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Institut Claudius Regaud
Indications
Therapies
Age Groups: adult | senior
Covered Countries FRA

Facility Status City State Zip Country Details
Institut Bergonié Bordeaux France Details
Centre Oscar Lambret Lille France Details
Centre Leon Berard Lyon France Details
Institut Regional Du Cancer de Montpellier Montpellier France Details
IUCT-O Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field